Compound information
- Natural Products
- ZC758655
- Molecular Formula
- C13H17N3O
- Molecular Weight
- 231.137162164 g/mol
- Structure
-
- IUPAC Name
- (3aR,6aR)-N-(3-pyridyl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide
- InChI
- InChI=1S/C13H17N3O/c17-13(15-12-5-2-6-14-7-12)16-8-10-3-1-4-11(10)9-16/h2,5-7,10-11H,1,3-4,8-9H2,(H,15,17)/t10-,11-/m0/s1
- InChI Key
- ZFDOAFOHXIHZBF-QWRGUYRKSA-N
- SMILES
- O=C(Nc1cccnc1)N1C[C@@H]2CCC[C@H]2C1
- Source
- ZINC000150820679
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 17 | Ring Count | 3 |
| Heteroatom Count | 4 | Rotatable Bond Count | 1 |
| Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
| Topological Polar Surface Area | 45.23 Å2 | LogP | 2.188 |
| LogS | -1.706 | LogD | 1.769 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.095 | Pgp substrate | 0.03 |
| HIA | 0.968 | F20 % | 0.994 |
| F30 % | 0.897 | Caco-2 | -4.787 |
| MDCK | -5.309 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.97 | PPB | 49.042 |
| VD | 1.565 | Fu | 0.282 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.423 | CYP1A2 substrate | 0.621 |
| CYP2A6 substrate | 0.762 | CYP2B6 substrate | 0.642 |
| CYP2C19 inhibitor | 0.049 | CYP2C19 substrate | 0.656 |
| CYP2C8 substrate | 0.515 | CYP2C9 inhibitor | 0.062 |
| CYP2C9 substrate | 0.885 | CYP2D6 inhibitor | 0.01 |
| CYP2D6 substrate | 0.909 | CYP2E1 substrate | 0.977 |
| CYP3A4 inhibitor | 0.345 | CYP3A4 substrate | 0.998 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.826 | CL | 9.864 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.088 | Hepatotoxicity | 0.923 |
| Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.186 |
| FDAMDD | 0.646 | Skin Sensitization | 0.973 |
| Carcinogenicity | 0.089 | Eye Corrosion | 0.049 |
| Eye Irritation | 0.745 | Respiratory Toxicity | 0.704 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.314 | IGC50 | 1.898 |
| LC50FM | 2.152 | LC50DM | -1.386 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.165 | NR-AR-LBD | 0.197 |
| NR-AhR | 0.329 | NR-Aromatase | 0.025 |
| NR-ER | 0.269 | NR-ER-LBD | 0.307 |
| NR-PPAR-gamma | 0.175 | SR-ARE | 0.061 |
| SR-ATAD5 | 0.462 | SR-HSE | 0.353 |
| SR-MMP | 0.63 | SR-p53 | 0.119 |
Similar covalent drugs
No similar covalent drugs found for this compound.